Related by context. All words. (Click for frequent words.) 71 caspofungin 71 mycophenolate mofetil 71 daunorubicin 71 idarubicin 70 dose cytarabine 70 irbesartan 70 chlorambucil 70 mycophenolate mofetil MMF 70 azacytidine 70 ritonavir boosted 70 IFN beta 69 calcineurin inhibitor 69 abacavir lamivudine 69 olmesartan 69 chlorthalidone 69 5FU 69 adriamycin 69 hematologic toxicity 69 ULORIC 69 bezafibrate 69 posaconazole 69 cranial irradiation 69 ximelagatran 69 fluorouracil 69 recurrent glioblastoma multiforme 68 SSc 68 imipenem 68 nephrotoxicity 68 colorectal adenoma 68 elevated LDH 68 metastatic malignant melanoma 68 Platinol ® cisplatin 68 mutated KRAS 68 lumbar spine BMD 68 TACE 68 IFN α 68 pamidronate 68 tirofiban 68 biologic DMARD 68 ritonavir boosted lopinavir 68 thalidomide Thalomid 68 alkylating agent 68 placebo dexamethasone 68 genotypic resistance 68 idraparinux 68 AST ALT 68 Natalizumab 68 doxorubicin docetaxel 68 relapsed MM 68 paricalcitol 68 HBeAg seroconversion 68 interferon IFN 68 calcineurin inhibitors 68 5-FU/LV 68 piperacillin tazobactam 68 trastuzumab Herceptin ® 68 abacavir Ziagen 68 IL 1ß 68 definite stent thrombosis 68 allogeneic stem cell 68 metastatic malignant 67 mitoxantrone 67 d4T stavudine Zerit 67 mg kg dose 67 lenalidomide dexamethasone 67 mycophenolic acid 67 cyclophosphamide methotrexate 67 flutamide 67 ABCB1 67 AZT zidovudine Retrovir 67 haematologic 67 aspirin clopidogrel 67 dalteparin 67 tenecteplase 67 GnRH agonists 67 Cyclosporine 67 trans retinoic acid 67 CLL SLL 67 β blockers 67 pegylated liposomal doxorubicin 67 μg ml 67 hepatic metastases 67 TNF α 67 unfractionated heparin UFH 67 vWF 67 pT3 67 prostate cancer CaP 67 angiotensin converting enzyme inhibitors 67 serum HBV DNA 67 serum cortisol 67 3TC lamivudine Epivir 67 tinzaparin 67 HBeAg negative patients 67 μmol L 67 iodixanol 67 fibrinolysis 67 efalizumab 67 eplerenone 67 hepatocellular carcinomas 67 Hazard Ratio 67 fibrinolytic 67 Doxil ® 67 APTIVUS r 67 interferon alfa 2b 67 pyrazinamide 67 epirubicin 67 Velcade bortezomib 67 octreotide LAR 67 ganciclovir 67 micafungin 67 doxorubicin cyclophosphamide 67 PSA nadir 67 serum creatinine levels 67 adefovir 67 intravenous dosing 67 certolizumab 67 rHuEPO 67 alanine aminotransferase 66 enalapril 66 ara C 66 intracranial hemorrhage ICH 66 allogeneic SCT 66 antiandrogen 66 saline placebo 66 rFVIIa 66 isoproterenol 66 tenofovir emtricitabine 66 FXIII 66 TNF antagonist 66 biochemical relapse 66 TMP SMX 66 glomerular filtration 66 CANCIDAS 66 alefacept 66 euthyroid 66 stavudine d4T 66 efavirenz EFV 66 indinavir 66 HBeAg negative 66 MULTAQ 66 intravesical therapy 66 pCR 66 hepatorenal syndrome 66 receiving VICTRELIS 66 Serum creatinine 66 antihypertensive therapy 66 immunosuppressive regimen 66 azacitidine 66 preoperative chemotherapy 66 serum urate 66 fosamprenavir 66 Decitabine 66 EGFR HER2 66 T2 lesions 66 corticosteroid therapy 66 decitabine 66 HBeAg positive patients 66 IFN alpha 66 HBeAg 66 intravenous bisphosphonates 66 CIMZIA ™ 66 ethambutol 66 ß blockers 66 Vaprisol 66 cis retinoic acid 66 isoenzyme 66 aspartate aminotransferase AST 66 Navelbine 66 goserelin 66 Torisel 66 deferoxamine 66 systemic corticosteroids 66 ergocalciferol 66 colorectal liver metastases 66 partial remissions 66 inducible nitric oxide synthase 66 nadolol 66 erythropoietic 66 receptor blocker 66 latanoprost 66 sirolimus 66 insulin detemir 66 Nilotinib 66 Flu Cy 66 HGPIN 66 glatiramer acetate 66 rituximab Rituxan 66 voriconazole 65 somatostatin analog 65 myelosuppressive 65 androgen deprivation 65 rhTSH 65 dose atorvastatin 65 mcg BID 65 APTIVUS 65 HMG CoA reductase inhibitor 65 external beam radiotherapy 65 advanced adenomas 65 -#.# log# 65 protease inhibitor PI 65 pegylated interferon alfa 65 Gleevec resistant 65 metastatic RCC 65 pentoxifylline 65 CHOP chemotherapy 65 BENICAR HCT 65 antibody titer 65 mitomycin C 65 atorvastatin #mg 65 6 mercaptopurine 65 epoetin alfa 65 bovine thrombin 65 nelfinavir 65 thromboembolic events 65 TEAEs 65 achieved ACR# 65 amphotericin B 65 neutrophil counts 65 vinorelbine 65 alanine aminotransferase ALT 65 vinca alkaloid 65 Lenalidomide 65 glycoprotein IIb IIIa inhibitors 65 serum phosphate levels 65 chemoradiotherapy 65 ddI 65 MGd 65 metastatic neuroendocrine tumors 65 boosted protease inhibitor 65 weekly subcutaneous injections 65 platelet reactivity 65 renal allograft 65 bendamustine 65 T2DM 65 K ras mutations 65 gemcitabine carboplatin 65 bleomycin 65 tumor necrosis 65 thyroglobulin 65 teriflunomide 65 virologic failure 65 Epirubicin 65 adalimumab 65 Pemetrexed 65 sUA 65 NSTE ACS 65 rFSH 65 ibandronate 65 mRCC 65 anthracycline containing 65 IFN gamma 65 desvenlafaxine succinate 65 β blocker 65 4mg/kg 65 methotrexate monotherapy 65 LEXIVA r 65 serum calcium levels 65 myeloablative 65 dose colchicine 65 effector function 65 thiazide diuretic 65 titrated glipizide 65 adalimumab Humira 65 p = NS 65 CR nPR 65 gemcitabine Gemzar 65 VAPRISOL 65 trimethoprim sulfamethoxazole 65 HSCT 65 antiandrogens 65 GHRH 65 nitrotyrosine 65 myeloproliferative diseases 65 intravenous cyclophosphamide 65 KRAS mutant tumors 65 Lucentis monotherapy 65 tamsulosin 65 apolipoprotein B 65 candidemia 65 EXJADE 65 cinacalcet 65 L asparaginase 65 hepatic enzymes 65 salmeterol fluticasone 65 triiodothyronine 65 postoperative chemotherapy 65 SGPT 65 comparator arm 65 endoxifen 65 interferon alfa 2a 65 Elitek 64 antithymocyte globulin 64 LOVENOX R 64 antimetabolite 64 LPV r 64 metastatic GIST 64 lactate dehydrogenase 64 PAOD 64 fludarabine cyclophosphamide 64 benazepril 64 LMWH 64 tipranavir r 64 nephrotoxic 64 poor metabolizers 64 beta blocker therapy 64 Pharmacokinetics PK 64 rhGH 64 invasive aspergillosis 64 nicardipine 64 coadministration 64 beta 1a 64 antithrombotic 64 Teriflunomide 64 erlotinib Tarceva ® 64 invasive candidiasis 64 pulmonary exacerbations 64 Capecitabine 64 dexamethasone Decadron 64 TNFalpha 64 undetectable HBV DNA 64 plasma renin activity 64 Dasatinib 64 liver transplant recipients 64 LHRH agonist 64 atheroma volume 64 serum concentrations 64 agonist induced 64 baseline LDH 64 etoposide 64 SCIg 64 hemoglobin Hb 64 Adefovir 64 HBeAg positive 64 tamoxifen Nolvadex ® 64 DAPT 64 DMARD 64 platelet inhibitor 64 FOLFOX4 64 CTEPH 64 inotropic 64 lopinavir r 64 Alkeran 64 antithrombotic therapy 64 Pred Forte 64 HMG CoA reductase inhibitors 64 HAART regimen 64 clodronate 64 thrombocytopenic 64 myopathy rhabdomyolysis 64 lipid lowering drugs 64 μg kg 64 sorafenib Nexavar 64 sirolimus stent 64 temsirolimus 64 dose dexamethasone 64 TPV r 64 liver histology 64 selective modulator 64 transgene expression 64 autologous SCT 64 azathioprine 64 alteplase 64 severe neutropenia 64 fluvastatin 64 Combination therapy 64 allogeneic hematopoietic stem cell 64 amprenavir 64 nitrofurantoin 64 histologic subtype 64 db db mice 64 mcg albinterferon alfa 2b 64 ALT flares 64 gemcitabine cisplatin 64 lipid lowering agents 64 fondaparinux 64 dimeglumine 64 oxycodone CR 64 metformin sulfonylurea 64 colorectal carcinoma 64 pegaptanib 64 adenoma recurrence 64 sirolimus eluting stents 64 EBRT 64 μg mL 64 unfractionated heparin 64 CIMZIA TM 64 darunavir ritonavir 64 dacarbazine 64 FOLFIRI 64 cefuroxime 64 sitosterol 64 VELCADE melphalan 64 grade cervical intraepithelial 64 vasopressor 64 hematologic parameters 64 tumor xenograft models 64 tiotropium bromide 64 paclitaxel Taxol 64 adefovir dipivoxil 64 colony stimulating factor 64 EGFR tyrosine kinase inhibitors 64 receiving highly emetogenic 64 transaminase elevations 64 TIMP 1 64 peginterferon 64 protease inhibitors PIs 64 amikacin 64 oral vancomycin 64 timolol 64 tenofovir DF 64 vWD 64 8mg/kg 64 CIMZIA TM certolizumab pegol 64 aprepitant 64 steroid dexamethasone 64 ACh 64 imatinib resistant 64 HER2 amplification 64 HER2 overexpression 64 pharmacokinetic interactions 64 prostanoid 64 Posaconazole 64 splenectomized patients 64 Fludara 64 complete cytogenetic response 64 DOXIL 64 cardiovascular calcification 64 lymphocytosis 64 atazanavir ritonavir 64 serum triglycerides 64 tacrolimus ointment 64 cytotoxic chemotherapy 64 oral allopurinol 64 angiotensin converting enzyme inhibitor 64 clomipramine 64 romiplostim 64 GP IIb IIIa inhibitors 64 tigecycline 64 serum phosphate 64 mutated K ras 64 Vidaza azacitidine 64 antiarrhythmic drugs 64 antiarrhythmic drug 64 transaminases 64 BEACOPP 64 microvessel density 64 fluticasone propionate FP 64 argatroban 64 imatinib therapy 64 hepatic enzyme 64 nucleoside analog 64 NMIBC 64 chemoradiation therapy 64 FOSRENOL ® 64 nonresponders 64 ABVD 64 Thal Dex 64 liver metastasis 64 cytotoxic effects 64 PegIFN RBV 64 CD4 + CD# 63 cidofovir 63 virological failure 63 mcg mL 63 esomeprazole 63 locoregional 63 lactate dehydrogenase LDH 63 K#N 63 verapamil 63 sotalol 63 metastatic renal cell carcinoma 63 IFN ß 63 neoadjuvant chemotherapy 63 conventional DMARDs 63 Fludarabine 63 pT2 63 refractory NSCLC 63 secondary hyperparathyroidism 63 anagrelide 63 HbF 63 mTOR inhibitors 63 macrolide antibiotic 63 trimethoprim 63 ALND 63 serum urate levels 63 IFN alfa 63 DMARDS 63 sulfasalazine 63 r hGH 63 leukocyte count 63 prostate carcinoma 63 cabazitaxel 63 TURBT 63 cefotaxime 63 fulvestrant 63 pg ml 63 mononuclear 63 splenectomized 63 prednisone prednisolone 63 epoetin alpha 63 immunomodulation 63 IV bisphosphonates 63 ursodeoxycholic acid 63 basiliximab 63 oxaliplatin Eloxatin 63 uM 63 microgram kg 63 cilostazol 63 tHcy 63 IOP lowering 63 CYPHER Stent 63 DFMO 63 cisplatin resistant 63 HLA A2 63 neoadjuvant therapy 63 insulin glulisine 63 mesalamine granules 63 RAS blockers 63 HbA 1c levels 63 pegylated interferon alpha 63 ritonavir boosted protease inhibitor 63 adjuvant radiotherapy 63 tolterodine 63 gliclazide 63 #mg/day [001] 63 radiotherapy RT 63 Dacogen decitabine 63 plasma folate 63 lymphadenectomy 63 Tacrolimus 63 estramustine 63 FluCAM arm 63 concurrent chemoradiation 63 CYP#C# [001] 63 octreotide 63 reinfarction 63 5-fluorouracil/leucovorin 63 amoxicillin clavulanate 63 Allogeneic 63 endoscopic remission 63 direct thrombin inhibitors 63 ACEIs 63 antiarrhythmic 63 nicotinic acid 63 azole 63 intravenous bolus 63 corticosteroid dose 63 inhibitor RG# 63 fibrinolytic therapy 63 SUVmax 63 pharmacologically active isomer 63 ceftriaxone 63 mCRC patients 63 invasive ductal 63 oblimersen 63 hematological parameters 63 microtubule inhibitor 63 riociguat 63 Neulasta ® 63 TORISEL 63 resectable 63 NPH insulin 63 ATACAND 63 apolipoproteins 63 somatostatin analogues 63 plasmacytoid 63 systemic corticosteroid 63 phenelzine 63 sargramostim 63 IgG1 63 tipranavir ritonavir 63 TAXOTERE R 63 crossclamp 63 DR4 63 liposomal doxorubicin 63 receptor tyrosine kinase inhibitor 63 Pgp 63 terazosin 63 ACE Inhibitor 63 eNOS 63 oral anticoagulant therapy 63 hepatoma 63 ARB telmisartan 63 mitomycin 63 neoplastic cells 63 anemia hemoglobin 63 RAS mutations 63 osteoblast 63 pretransplant 63 eculizumab therapy 63 Platinol ® 63 Double Blind Randomized 63 angiographic restenosis 63 Aptivus ® 63 nondiabetic patients 63 FVIII 63 serum testosterone 63 calcitriol 63 rizatriptan 63 docetaxel chemotherapy 63 candesartan cilexetil 63 immunomodulatory therapy 63 d4T 63 letrozole Femara 63 mg/m2 dose 63 QVAR R 63 Interferon alfa 63 factor TNF 63 paclitaxel cisplatin 63 ERK1 2 63 lymphocyte counts 63 lispro 63 gadobutrol 63 serum ALT 63 sipuleucel T 63 OPCAB 63 leukemia AML 63 Ceplene/IL-2 63 LV ejection fraction 63 fluticasone salmeterol 63 dose dependently 63 multikinase inhibitor 63 Epivir HBV 63 μg L 63 active metabolite 63 radical nephrectomy 63 Pioglitazone 63 carboplatin paclitaxel 63 darbepoetin alfa 63 neurological manifestations 63 BoNT 63 docetaxel Taxotere ® 63 Fluorouracil 63 PASI scores 63 stage IIIB 63 drotrecogin alfa activated 63 ug kg 63 Myelodysplastic Syndrome MDS 63 corticosteroid dexamethasone 63 tocilizumab 63 oxcarbazepine 63 ertapenem 63 DOXIL ® 63 interferon alfa 63 posttreatment 63 HER2 expression 63 unstable angina pectoris 63 ALT elevation 63 PTHrP 63 alkylating 63 antiplatelet agent 63 polymyxin B 63 fluoropyrimidine 63 elevated serum creatinine 63 sarcomatoid 63 liposomal amphotericin B 63 aspartate aminotransferase 63 galiximab 63 leflunomide 63 sirolimus eluting stent 63 A1PI 63 cerebral vasospasm 63 GW# [003] 63 ARIXTRA 63 MEVACOR 63 urothelial carcinoma 63 creatinine ratio 63 mucinous 63 stage IIIb IV 63 cellularity 63 pegylated interferons 63 bile acid sequestrant 63 daily subcutaneous injections 63 lymphocyte count 63 trabectedin 63 melphalan prednisone 63 macroalbuminuria 63 glulisine 63 LHRH agonists 63 receiving prophylactic anticoagulation 63 mcg QD 63 hepatic glucose production 63 infliximab 63 TNF alpha inhibitor 63 Pegylated Interferon 63 multivariable analysis 63 heparanase 63 dosage regimens 63 syngeneic 63 p = #.# [003] 63 achieved statistical significance 63 ancrod 63 Peg IFN 63 lanthanum carbonate 63 demonstrated antitumor activity 63 P = .# 63 mycophenolate 63 revascularization procedures 62 immunoconjugate 62 glomerular 62 Losartan 62 alkaline phosphatase 62 #beta estradiol 62 myelodysplastic myeloproliferative diseases 62 nucleoside analogues 62 PSADT 62 plus methotrexate 62 GSTT1 62 intestinal metaplasia 62 vincristine doxorubicin 62 tibolone 62 hypercalcemia 62 mg TID 62 oral anticoagulation 62 factor Xa 62 MCyR 62 pimecrolimus cream 62 gastrointestinal stromal tumors GISTs 62 vasoactive 62 ribavirin RBV 62 peginterferon alfa 2a 62 superficial bladder cancer 62 castrate resistant 62 transaminase levels 62 Interferon beta 62 cyclophosphamide Cytoxan 62 CCyR 62 hypophosphatemia 62 Pegylated Liposomal Doxorubicin 62 XELOX 62 ERBB2 62 HBeAg + 62 DAS# remission 62 vitamin D2 62 Xanafide 62 mg BID 62 hydroxymethyl coenzyme 62 dose melphalan 62 variceal hemorrhage 62 -#.# ± [002] 62 Cloretazine 62 pertussis toxin 62 Platinol 62 moderately emetogenic 62 EDSS scores 62 intravesical 62 gefitinib Iressa 62 elevated transaminases 62 subcutaneously administered 62 deferiprone 62 left ventricular systolic 62 viral titers 62 thromboembolism 62 pegIFN 62 trans retinoic acid ATRA 62 bisoprolol 62 mecamylamine 62 adjunctive placebo 62 Fas ligand 62 antidiabetic 62 FUSILEV enhances 62 simvastatin ezetimibe 62 NRTI 62 thyrotropin 62 GPIIb IIIa inhibitors 62 danazol 62 mRNA expression 62 nonalcoholic steatohepatitis NASH 62 ribavirin therapy 62 serum triglyceride levels 62 chemoresistant 62 bicalutamide 62 ACTEMRA TM 62 NRTI resistance 62 intravitreal injections 62 cytostatic 62 hypercholesterolaemia 62 concomitant medications 62 rt PA 62 hypokalemia 62 bosentan 62 mg clopidogrel 62 chronic idiopathic thrombocytopenic purpura 62 coronary stenosis 62 pyrimidine 62 sCD# 62 CAELYX 62 conjugated estrogen 62 BARACLUDE ® 62 seropositive patients 62 MIC# [001] 62 pentamidine 62 concomitant AEDs 62 metaplasia 62 Lp PLA 2 62 ALT normalization 62 bladder carcinoma 62 plasma uric acid 62 Vidofludimus 62 regorafenib 62 KRAS mutations 62 thrombocytopenic patients 62 CLA isomers 62 MYLOTARG 62 indapamide 62 aldosterone antagonists 62 GnRH agonist 62 serum albumin 62 angiotensin II receptor blocker 62 beta interferons 62 ropivacaine 62 allopurinol 62 beta blocker atenolol 62 trastuzumab 62 Hycamtin ® 62 vasodilatory 62 pramlintide metreleptin combination 62 neutrophil count 62 DAS# scores 62 MabCampath 62 5 fluorouracil 62 neutropaenia 62 medroxyprogesterone acetate 62 low dose cytarabine 62 lupus nephritis 62 pegylated alpha interferon 62 tapentadol ER 62 Helicobacter pylori eradication 62 biochemical recurrence 62 PBMCs 62 cisplatin gemcitabine 62 hA# 62 alfuzosin 62 active comparator 62 pyridostigmine 62 epoetin beta 62 erlotinib Tarceva 62 neointimal hyperplasia 62 relapsed ovarian cancer 62 MAGE A3 ASCI 62 nonoperative 62 SCCHN 62 Telintra 62 cisplatin chemotherapy 62 SLNB 62 HIF 1a 62 Estrogen Receptor 62 rabeprazole 62 CYT# potent vascular disrupting 62 inotropic agents 62 debulking surgery 62 ketorolac 62 interleukin IL 62 serum lipid levels 62 heavily pretreated patients 62 mTOR mammalian target 62 locoregional disease 62 serous ovarian cancer 62 PREZISTA r 62 NIHSS 62 busulfan 62 norethindrone 62 NovoTTF 62 salmeterol fluticasone propionate 62 haematopoietic 62 BEXXAR Therapeutic Regimen 62 tipranavir 62 dexmedetomidine 62 pg mL 62 antibody titers 62 thrombogenic 62 Erlotinib 62 baseline HbA1c 62 simvastatin #mg 62 Triapine R 62 completely resected 62 colon carcinoma 62 chemotherapeutic regimen 62 therapeutic regimens 62 indinavir Crixivan 62 zoledronic acid 62 scintigraphic 62 electrical cardioversion 62 Ranolazine 62 plus dexamethasone 62 Bosentan 62 curative resection 62 DMARDs 62 FLT3 62 Gliadel Wafer 62 ovarian carcinoma 62 heparins 62 nutlin 3a 62 alkylating agents 62 squamous histology 62 glucocorticoid 62 serum retinol 62 pyrimethamine 62 sitaxsentan 62 NMDA antagonists 62 elotuzumab 62 T2 lesion volume 62 lipid lowering therapy 62 total thyroidectomy 62 virological response 62 peginterferon alfa 2b 62 cytoreductive nephrectomy 62 beta lactam antibiotic 62 FOLPI 62 somatostatin analogs 62 bypass grafting 62 H. pylori eradication 62 selective agonist 62 IIIa inhibitors 62 amifostine 62 timepoints 62 adjunctive ABILIFY 62 Taxotere ® 62 dose cyclophosphamide 62 HBsAg 62 angiotensin II receptor antagonist 62 ß carotene 62 Angiotensin Converting Enzyme 62 Cardiotoxicity 62 mitoxantrone chemotherapy 62 immunosuppressive therapies 62 immunosuppressives 62 triacylglycerol 62 mineralocorticoid 62 chronic eosinophilic leukemia 62 TKI therapy 62 myelosuppression 62 antiangiogenic agent 62 tazobactam 62 thalidomide dexamethasone 62 denileukin diftitox 62 aldosterone antagonist 62 F FLT 62 IXEMPRA 62 Ramipril 62 pmol L 62 urinary N telopeptide 62 follicular lymphoma FL 62 pan HDAC inhibitor 62 hypomagnesemia 62 rebleeding 62 leukopenia 62 adjuvant tamoxifen 62 pegylated interferon alfa 2b 62 mg QD 62 levetiracetam 62 leucopenia 62 standard chemotherapy regimens 62 pomalidomide 62 cilengitide 62 invasive carcinomas 62 FK# 62 kidney allograft 62 inhaled budesonide 62 mitoxantrone plus 62 papillary renal cell carcinoma 62 anthracycline taxane 62 PTPN# 62 CYP #D# 62 myeloperoxidase 62 MELD scores 62 epithelial tumors 62 Fibrates 62 C#BL 6 mice 62 beta1 62 statistically significant p = 62 lesional 62 HoFH 62 mL/min/#.# m 2 62 amphotericin 62 refractory AML 62 PROSTVAC VF 62 clopidogrel Plavix 62 alkaline phosphatase ALP 62 elastase 62 mCi kg 62 albumin excretion rate 62 pegfilgrastim 62 Trastuzumab 62 chemotherapeutic regimens 62 ziconotide 62 Rituximab 62 doxorubicin HCl liposome injection 62 aminotransferases 62 ISTODAX 62 VEGF inhibitors 62 verteporfin 62 arterial thromboembolic events 62 cTnI 62 lanreotide 62 neointimal 62 elevated ALT 62 Neutropenia 62 histological subtype